Instituto de Evaluación de Tecnologías en Salud e Investigación-IETSI, ESSALUD, Lima, Peru.
Departamento de Nefrología, Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru.
BMJ Open. 2024 Jan 6;14(1):e076217. doi: 10.1136/bmjopen-2023-076217.
To externally validate the four-variable kidney failure risk equation (KFRE) in the Peruvian population for predicting kidney failure at 2 and 5 years.
A retrospective cohort study.
17 primary care centres from the Health's Social Security of Peru.
Patients older than 18 years, diagnosed with chronic kidney disease stage 3a-3b-4 and 3b-4, between January 2013 and December 2017. Patients were followed until they developed kidney failure, died, were lost, or ended the study (31 December 2019), whichever came first.
Performance of the KFRE model was assessed based on discrimination and calibration measures considering the competing risk of death.
We included 7519 patients in stages 3a-4 and 2798 patients in stages 3b-4. The estimated cumulative incidence of kidney failure, accounting for competing event of death, at 2 years and 5 years, was 1.52% and 3.37% in stages 3a-4 and 3.15% and 6.86% in stages 3b-4. KFRE discrimination at 2 and 5 years was high, with time-dependent area under the curve and C-index >0.8 for all populations. Regarding calibration in-the-large, the observed to expected ratio and the calibration intercept indicated that KFRE underestimates the overall risk at 2 years and overestimates it at 5 years in all populations.
The four-variable KFRE models have good discrimination but poor calibration in the Peruvian population. The model underestimates the risk of kidney failure in the short term and overestimates it in the long term. Further research should focus on updating or recalibrating the KFRE model to better predict kidney failure in the Peruvian context before recommending its use in clinical practice.
在秘鲁人群中对四变量肾衰竭风险方程(KFRE)进行外部验证,以预测 2 年和 5 年时的肾衰竭。
回顾性队列研究。
秘鲁健康社会保障的 17 个基层医疗中心。
年龄大于 18 岁,诊断为慢性肾脏病 3a-3b-4 期和 3b-4 期的患者,时间为 2013 年 1 月至 2017 年 12 月。患者随访至肾衰竭、死亡、失访或研究结束(2019 年 12 月 31 日),以先发生者为准。
基于考虑死亡竞争风险的判别和校准测量,评估 KFRE 模型的性能。
我们纳入了 7519 例 3a-4 期患者和 2798 例 3b-4 期患者。考虑到死亡竞争事件,2 年和 5 年时肾衰竭的估计累积发生率,在 3a-4 期分别为 1.52%和 3.37%,在 3b-4 期分别为 3.15%和 6.86%。2 年和 5 年时 KFRE 的判别能力较高,所有人群的时间依赖性曲线下面积和 C 指数均>0.8。关于大范围内的校准,观察到的与预期的比值和校准截距表明,KFRE 在所有人群中均低估了 2 年时的总体风险,而高估了 5 年时的风险。
在秘鲁人群中,四变量 KFRE 模型具有良好的判别能力,但校准能力较差。该模型在短期内低估了肾衰竭的风险,而在长期内则高估了肾衰竭的风险。在推荐其在临床实践中使用之前,应进一步研究更新或重新校准 KFRE 模型,以更好地预测秘鲁人群的肾衰竭风险。